0001585364-23-000115.txt : 20230710 0001585364-23-000115.hdr.sgml : 20230710 20230710131812 ACCESSION NUMBER: 0001585364-23-000115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230707 FILED AS OF DATE: 20230710 DATE AS OF CHANGE: 20230710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ives Alison CENTRAL INDEX KEY: 0001932375 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36353 FILM NUMBER: 231079166 MAIL ADDRESS: STREET 1: C/O PERRIGO COMPANY PLC STREET 2: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO Co plc CENTRAL INDEX KEY: 0001585364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THE SHARP BUILDING STREET 2: HOGAN PLACE CITY: DUBLIN 2 STATE: L2 ZIP: D02 TY74 BUSINESS PHONE: 269-673-8451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 FORMER COMPANY: FORMER CONFORMED NAME: PERRIGO Co Ltd DATE OF NAME CHANGE: 20130828 4 1 wf-form4_168900947961719.xml FORM 4 X0407 4 2023-07-07 0 0001585364 PERRIGO Co plc PRGO 0001932375 Ives Alison C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010 0 1 0 0 EVP & Chief Scientific Officer 0 Ordinary Shares 2023-07-07 4 M 0 920 32.63 A 8611 D Ordinary Shares 2023-07-07 4 F 0 271 32.63 D 8340 D Restricted Stock Units 2023-07-07 4 M 0 920 D Ordinary Shares 920.0 1839 D Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. /s/ Victor Torres, attorney-in-fact for Ms. Alison Ives 2023-07-10 EX-24 2 bezerrapoa.htm POA

POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of Todd W. Kingma, John Castanos and Victor Torres, signing singly, as the undersignedTMs true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersignedTMs capacity as an officer and/or director of Perrigo Company plc (the Company), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-factTMs discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do any and all things and take any and all actions necessary in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-factTMs substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersignedTMs responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersignedTMs holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of 25 May 2022.
Alison Ives, EVP, Chief Scientific Officer